| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $245.4M | +19.6% |
| SG&A Expense | $48.1M | +29.0% |
| Operating Income | -$293.6M | -21.1% |
| Interest Expense | $4.0M | — |
| Income Tax | $0 | — |
| Net Income | -$295.4M | -22.1% |
| EPS (Basic) | -$17.23 | -17.8% |
| EPS (Diluted) | -$17.23 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $331.5M | +814.1% |
| Current Assets | $361.4M | +33.0% |
| Total Assets | $362.6M | +32.6% |
| Current Liabilities | $115.9M | +50.8% |
| Long-term Debt | $69.7M | — |
| Total Liabilities | $165.2M | +113.9% |
| Stockholders' Equity | $197.4M | +0.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$224.9M | -22.3% |
| Capital Expenditures | $217K | +3.8% |
| Investing Cash Flow | $206.7M | +4188.7% |
| Financing Cash Flow | $313.5M | +83.1% |
| Free Cash Flow | -$225.1M | -22.2% |